we developed novel immunohistochemistry (IHC) detection kits for CLDN-6, CLDN-9, and CLDN-18.2 to facilitate their use as diagnostic and therapeutic biomarkers. Methods: We used AI-designed peptides ...

German Cancer Research Center, Heidelberg, Germany.